Anthrax Vaccine Uses Nanoparticles to Produce Immunity August 16, 2007 Newswise, Aug. 16, 2007 A nasal vaccine for anthrax showed strong promise in initial animal studies, according to scientists at the University of Michigan. Because of the biosafety restrictions on the use of anthrax, the challenge experiments were done at the University of Texas Medical Branch, which have labs federally approved for handling the pathogen. « Back | The Newsroom »